Global /France /Healthcare /Biotechnology /ALGAE
chevron_leftBack

Fermentalg S.A.

ALGAE
EPA: ALGAE Delayed
0.3180EUR -1.6%
0.3604 USD
As of 24 April 2025, Fermentalg S.A. has a market cap of $41.1M USD, ranking #25876 globally and #369 in France. It ranks #2616 in the Healthcare sector, and #843 in the Biotechnology industry.
Global Rank
25876
Country Rank
369
Sector Rank
2616
Industry Rank
843
Key Stats
Market Cap
$41.1MUSD
36.12M EUR
Enterprise Value
$31.89MUSD
28.14M EUR
Revenue (TTM)
$13.08MUSD
11.5M EUR
EBITDA (TTM)
-$9.42MUSD
-8.31M EUR
Net Income (TTM)
-$14.65MUSD
-12.88M EUR
EBITDA Margin
-72%
Profit Margin
-112%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Pierre Josselin open_in_new
Employees
70
Founded
2009
Website
fermentalg.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.6% -1.5% -18% -12% -11% -45%

Markets

Exchange Ticker Price
Euronext Paris
MIC: XPAR
PRIMARY
ALGAE
Fermentalg SA
ISIN: FR0011271600
Shares Out.:
87.706M1 Shares Float: 71.255M2
TV:
SA:
YF:
GF:
BA:
MS:
0.3180 EUR
London Stock Exchange
MIC: XLON
0QTJ
Fermentalg SA
ISIN: FR0011271600
TV:
SA:
YF:
GF:
BA:
MS:
0.3300 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Fermentalg S.A.

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

Similar Companies

Industry: Biotechnology (France)
Name
Market Cap diff.
Valneva SE
VLA
$599.15M
526.51M EUR
1K%
MedinCell S.A.
MEDCL
$553.07M
486.02M EUR
1K%
ABIVAX Société Anonyme
ABVX
$435.81M
382.98M EUR
960%
Inventiva S.A.
IVA
$350.53M
308.03M EUR
753%
DBV Technologies S.A.
DBV
$227.71M
200.1M EUR
454%
Industry: Biotechnology (Global)
Name
Market Cap diff.
Vertex Pharmaceuticals Inc.
VRTX
$126.59B
308K%
CSL Ltd.
CSL
$74.13B
116.09B AUD
180K%
Regeneron Pharmaceuticals, Inc.
REGN
$62.91B
153K%
Samsung Biologics Co.,Ltd.
207940
$52.85B
75.87T KRW
128K%
argenx SE
ARGX
$36.66B
32.22B EUR
89K%